{"id":"afb71f19-1e83-542d-b6c9-dba434845353","stable_key":"4fef8d72-f107-5eb5-b2fb-483ca85465e0:k2-warfarin-mgp","predicate":"increases","statement":"Warfarin-treated vascular cells produced uncarboxylated MGP and accumulated more calcium salts than controls.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"8b9bf8fa-af74-5593-aaa9-7b2985fd1cb1","mechanism_event_label":"Changing the vitamin K cycle changed the protein state and the mineral-deposition outcome in these cells.","subject":{"id":"ee94b256-deeb-5795-8b6e-6e388576d464","slug":"warfarin","display_name":"Warfarin","entity_type_key":"small_molecule"},"object":{"id":"0270f1bb-66ca-5efa-940b-351a3266214f","slug":"uncarboxylated-mgp","display_name":"Uncarboxylated matrix Gla protein","entity_type_key":"protein_state"},"evidence_count":1,"mechanism_event":{"id":"8b9bf8fa-af74-5593-aaa9-7b2985fd1cb1","stable_key":"4fef8d72-f107-5eb5-b2fb-483ca85465e0:k2-warfarin-mgp-event","event_type":"biochemical_relationship","label":"Changing the vitamin K cycle changed the protein state and the mineral-deposition outcome in these cells.","description":"Warfarin-treated vascular cells produced uncarboxylated MGP and accumulated more calcium salts than controls.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"2917b2ff-96cb-5cd1-a390-b10026f1826d","slug":"vascular-smooth-muscle-calcification","display_name":"Vascular smooth muscle cell matrix calcification","entity_type_key":"cellular_process"},"role":"outcome","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ee94b256-deeb-5795-8b6e-6e388576d464","slug":"warfarin","display_name":"Warfarin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"0270f1bb-66ca-5efa-940b-351a3266214f","slug":"uncarboxylated-mgp","display_name":"Uncarboxylated matrix Gla protein","entity_type_key":"protein_state"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/k2-research/17848178.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27\", \"start_char\": 0, \"end_char\": 1745, \"text_sha256\": \"d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human vascular-cell calcification and synthetic-peptide assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Elevated calcium, warfarin, K1 and modified MGP peptides","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Vitamin K1 intervention in cells; K2-specific efficacy and human arterial reversal were not tested.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"k2","display_name":"Vitamin K2 / menaquinone family","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Human vascular smooth muscle cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Changing the vitamin K cycle changed the protein state and the mineral-deposition outcome in these cells.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[k2-p17848178] Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. (2007). https://pubmed.ncbi.nlm.nih.gov/17848178/ DOI: 10.1111/j.1538-7836.2007.02758.x","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Extracellular matrix and vesicle-like surfaces","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"d474fb39-7764-5b1f-a26d-cac1b3bbe21a","evidence_kind":"source_excerpt","locator":"Lines 539-550","start_line":539,"end_line":550,"excerpt":"### k2-warfarin-mgp\nWarfarin-treated vascular cells produced uncarboxylated MGP and accumulated more calcium salts than controls.\nCondition category: machinery_impairment\nnutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Changing the vitamin K cycle changed the protein state and the mineral-deposition outcome in these cells.\norganism: Human vascular smooth muscle cells\ntissue_or_cell_type: Extracellular matrix and vesicle-like surfaces\nexperimental_model: Human vascular-cell calcification and synthetic-peptide assays\nlimitations: Vitamin K1 intervention in cells; K2-specific efficacy and human arterial reversal were not tested.\nexposure: Elevated calcium, warfarin, K1 and modified MGP peptides\nevidence_span: {\"source_cache\": \"artifacts/k2-research/17848178.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27\", \"start_char\": 0, \"end_char\": 1745, \"text_sha256\": \"d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27\"}\n[k2-p17848178] Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. (2007). https://pubmed.ncbi.nlm.nih.gov/17848178/ DOI: 10.1111/j.1538-7836.2007.02758.x","model_system":"Human vascular-cell calcification and synthetic-peptide assays","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [k2-p17848178] Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. (2007). https://pubmed.ncbi.nlm.nih.gov/17848178/ DOI: 10.1111/j.1538-7836.2007.02758.x","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dfeae572-af3d-5042-a10e-e67596f9ab28","stable_key":"import-4fef8d72-f107-5eb5-b2fb-483ca85465e0","title":"Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"dc31aff21110d09b025c177e03b4c5ca8349d52bf5f962285fdbfcf660c0e4f6","revision_id":"850887db-34f6-55aa-9d3e-b8fd3a4a5de3","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}